DrugPatentWatch Database Preview
Profile for Australia Patent: 2003206924
US Patent Family Members and Approved Drugs for Australia Patent: 2003206924
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Feb 19, 2023 | Astrazeneca Pharms | DALIRESP | roflumilast |
➤ Sign Up | Feb 19, 2023 | Astrazeneca Pharms | DALIRESP | roflumilast |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |